Otero, RemediosBertoletti, LaurentMuriel, AlfonsoSiniscalchi, CarmineJimenez, CarmenLuis Lobo, JoseKigitovica, DanaQuintavalla, RobertoRocci, AnnaJara-Palomares, LuisMonreal, Manuel2023-01-252023-01-252018-04-19Otero R, Bertoletti L, Muriel A, Siniscalchi C, Jimenez C, Luis Lobo J, et al. Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy. Eur Respir J. 2018 Apr 19;51(4):1702576.0903-1936http://hdl.handle.net/10668/12201Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and serious complication after pulmonary embolism (PE). Its incidence in the general population is around 3–30 cases per million. The incidence of CTEPH after acute PE ranges between 0.1 and 8.8% [1–5]. In a meta-analysis including 4047 PE patients, the incidence of CTEPH was 2.8% (95% CI 1.5–4.1) in “PE survivors” without major comorbidities [6]. In studies not using objective diagnostic criteria to diagnose CTEPH, the pooled incidence was 6.3% (95% CI 4.1–8.4)enDecision Support TechniquesEuropeHypertension, PulmonaryPulmonary EmbolismEchocardiographyHumansPredictive Value of TestsRegistriesThromboembolismletter to the editor29496752Restricted AccessIncidenciaEmbolia pulmonarHipertensión pulmonarTromboembolia venosaEnfermedad aguda10.1183/13993003.02576-20171399-3003https://erj.ersjournals.com/content/erj/51/4/1702576.full.pdf